Granich R

Human immunodeficiency virus funding and access to treatment in sub-Saharan Africa
Granich R, Gupta S, Williams BG

International Journal of STD & AIDS

(2022)

https://doi.org/10.1177/09564624211042287
Treatment as prevention trials and ending AIDS: what do we know when did we know it, and what did we do?
Granich R, Williams BG

Current Opinion in HIV and AIDS

(2019)

https://doi.org/10.1097/COH.0000000000000582
Questionable assumptions mar modelling of Kenya home-based testing campaigns
Granich R, Gupta S, Williams BG

Journal of the International AIDS Society

(2019)

https://doi.org/10.1002/jia2.25230
Modeling the HIV Epidemic: Why the 95-95-95 Target and ART Effectiveness Parameters Matter
Granich R, Gupta S, Wollmers M, Ruffner M, Williams BG

International Journal of Virology and AIDS

(2018)

https://doi.org/10.23937/2469-567X/1510041
90-90-90, epidemic control and ending AIDS: global situation and recommendations
Granich R, Gupta S, Williams BG

International Journal of Virology and AIDS

(2018)

https://doi.org/10.23937/2469-567X/1510043
HIV, 95-95-95 and the allocative efficiency fallacy: why treating everyone makes sense from a humanitarian, clinical, economic and disease control perspective
Granich R, Gupta S, Williams BG

Journal of the International AIDS Society

(2018)

https://doi.org/10.1002/jia2.25191
Ending AIDS: myth or reality?
Williams BG, Granich R

The Lancet

(2017)

https://doi.org/10.1016/S0140-6736(17)31832-9
90-90-90 and ending AIDS: necessary and feasible
Granich R, Williams BG, Montaner J, Zuniga JM

The Lancet

(2017)

https://doi.org/10.1016/S0140-6736(17)31872-X
Progress and prospects for the control of HIV and tuberculosis in South Africa: a dynamical modelling study
Williams BG, Gupta S, Wollmers W, Granich R

The Lancet Public Health

(2017)

https://doi.org/10.1016/S2468-2667(17)30066-X
The impact and cost of ending AIDS in Botswana
Williams BG, Gupta S, Wollmers M, Granich R

The Lancet HIV

(2016)

https://doi.org/10.1016/S2352-3018(16)30116-3
Pattern, determinants, and impact of HIV spending on care and treatment in 38 high-burden low- and middle-income countries
Granich R, Gupta S, Montaner J, Williams BG, Zuniga JM

Journal of the International Association for Providers of AIDS Care

(2016)

https://doi.org/10.1177/2325957415623261
HIV treatment: time to lean forward
Granich R, Williams BG

The Lancet

(2016)

https://doi.org/10.1016/S0140-6736(15)01293-3
Potential impact of the US President’s Emergency Plan for AIDS relief on the tuberculosis/HIV coepidemic in selected Sub-Saharan African countries
Lima VD, Granich R, Phillips P, Williams BG, Montaner J

Journal of Infectious Diseases

(2013)

https://doi.org/10.1093/infdis/jit406
The potential impact of expanding antiretroviral therapy and combination prevention in Vietnam: towards elimination of HIV transmission
Kato M, Granich R, Bui DD, Tran HV, Nadol P, Jacka D, Sabin K, Suthar AB, Mesquita F, Lo YR, Williams BG

Journal of Acquired Immune Deficiency Syndromes

(2013)

https://doi.org/10.1097/QAI.0b013e31829b535b
Examining the evidence on the causal effect of HAART on transmission of HIV using the Bradford Hill criteria
Nosyk B, Audoin B, Beyrer C, Cahn P, Granich R, Havlir D, Katabira E, Lange J, Lima VD, Patterson T, Strathdee SA, Williams BG, Montaner J

AIDS

(2013)

https://doi.org/10.1097/QAD.0b013e32835f1d68
Fifteen million people on antiretroviral treatment by 2015: treatment as prevention
Williams BG, Granich R, Montaner J

Current Opinion in HIV and AIDS

(2013)

https://doi.org/10.1097/COH.0b013e32835b80dd
Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011-2050
Granich R, Kahn JG, Bennett R, Holmes CB, Garg N, Serenata C, Sabin ML, Makhlouf-Obermeyer C, De Mack CF, Williams P, Jones L, Smyth C, Kutch KA, Ying-Ru L, Vitoria M, Souteyrand Y, Crowley S, Korenromp EL, Williams BG

PLoS One

(2012)

https://doi.org/10.1371/journal.pone.0030216
Role of acute infection in HIV transmission
Williams BG, Granich R, Dye C

The Lancet

(2011)

https://doi.org/10.1016/S0140-6736(11)61832-1
Antiretroviral therapy in prevention of HIV and TB: update on current research efforts
Granich R, Gupta S, Suthar AB, Smyth C, Hoos D, Vitoria M, Simao M, Hankins C, Schwartlander B, Ridzon R, Bazin B, Williams BG, Lo YR, McClure C, Montaner J, Hirnschall G, ART in Prevention of HIV TB Research Writing Group

Current HIV Research

(2011)

https://doi.org/10.2174/157016211798038597
Harnessing the prevention benefits of antiretroviral therapy to address HIV and tuberculosis
Granich R, Lo YR, Suthar AB, Vitoria M, Baggaley R, Obermeyer CM, McClure C, Souteyrand Y, Perriens J, Kahn JG, Bennett R, Smyth C, Williams BG, Montaner J, Hirnschall G

Current HIV Research

(2011)

https://doi.org/10.2174/157016211798038551
Costing human rights and community support interventions as a part of universal access to HIV treatment and care in a Southern African setting
Jones L, Akugizibwe P, Clayton M, Amon JJ, Sabin ML, Bennett R, Stegling C, Baggaley R, Kahn JG, Holmes CB, Garg N, Obermeyer CM, Mack CD, Williams P, Smyth C, Vitoria M, Crowley S, Williams BG, McClure C, Granich R, Hirnschall G

Current HIV Research

(2011)

https://doi.org/10.2174/157016211798038614
Cost-effectiveness of antiretroviral therapy for prevention
Kahn JG, Marseille EA, Bennett R, Williams BG, Granich R

Current HIV Research

(2011)

https://doi.org/10.2174/157016211798038542
Highly active antiretroviral treatment as prevention of HIV transmission
Granich R, Crowley S, Vitoria M, Lo YR, Souteyrand Y, Dye C, Gilks C, Guerma T, De Cock KM, Williams BG

Journal of the International AIDS Society

(2010)

https://doi.org/10.1186/1758-2652-13-1
Highly active antiretroviral treatment as prevention of HIV transmission: review of scientific evidence and update
Granich R, Crowley S, Vitoria M, Smyth C, Kahn JG, Bennett R, Lo Y, Souteyrand Y, Williams BG

Current opinion in HIV and AIDS

(2010)

https://doi.org/10.1097/coh.0b013e32833a6c32
Prevention of tuberculosis in people living with HIV
Granich R, Akolo C, Gunneberg C, Getahun H, Williams P, Williams BG

Clinical Infectious Diseases

(2010)

https://doi.org/10.1086/651494

12 Next

Granich R

Human immunodeficiency virus funding and access to treatment in sub-Saharan Africa

Treatment as prevention trials and ending AIDS: what do we know when did we know it, and what did we do?

Questionable assumptions mar modelling of Kenya home-based testing campaigns

Modeling the HIV Epidemic: Why the 95-95-95 Target and ART Effectiveness Parameters Matter

90-90-90, epidemic control and ending AIDS: global situation and recommendations

HIV, 95-95-95 and the allocative efficiency fallacy: why treating everyone makes sense from a humanitarian, clinical, economic and disease control perspective

Ending AIDS: myth or reality?

90-90-90 and ending AIDS: necessary and feasible

Progress and prospects for the control of HIV and tuberculosis in South Africa: a dynamical modelling study

The impact and cost of ending AIDS in Botswana

Pattern, determinants, and impact of HIV spending on care and treatment in 38 high-burden low- and middle-income countries

HIV treatment: time to lean forward

Potential impact of the US President’s Emergency Plan for AIDS relief on the tuberculosis/HIV coepidemic in selected Sub-Saharan African countries

The potential impact of expanding antiretroviral therapy and combination prevention in Vietnam: towards elimination of HIV transmission

Examining the evidence on the causal effect of HAART on transmission of HIV using the Bradford Hill criteria

Fifteen million people on antiretroviral treatment by 2015: treatment as prevention

Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011-2050

Role of acute infection in HIV transmission

Antiretroviral therapy in prevention of HIV and TB: update on current research efforts

Harnessing the prevention benefits of antiretroviral therapy to address HIV and tuberculosis

Costing human rights and community support interventions as a part of universal access to HIV treatment and care in a Southern African setting

Cost-effectiveness of antiretroviral therapy for prevention

Highly active antiretroviral treatment as prevention of HIV transmission

Highly active antiretroviral treatment as prevention of HIV transmission: review of scientific evidence and update

Prevention of tuberculosis in people living with HIV

Type

Year

Author